The macro picture looks extraordinarily bright for electric vehicle charging infrastructure company ChargePoint (NYSE:CHPT), even if some of the sheen has been taken off CHPT stock this year. Source: David Tonelson / Shutterstock.com The company’s strong second-quarter earnings report was largely overlooked. After an initial post-earnings pop, CHPT stock is down more than 10% since
Stocks to buy
The last time I weighed in on Plug Power (NASDAQ:PLUG), I said that investors interested in hydrogen stocks should use their current weakness as a buying opportunity. That was on Sept. 22, at which time PLUG stock closed at $26.92. Source: Alexander Kirch / Shutterstock.com While PLUG has since pulled back to $25.06 at the
It seemed natural for shares of Chinese electric vehicle maker Nio (NYSE:NIO) to correct after surging from $2.11 in March 2020 to a high just below $67 in January — a gain of more than 3,000% in less than 10 months. Additionally, factors like the chip shortage and regulatory headwinds in China negatively impacted investor
It has been six months since the Archegos Capital blow-up sank ViacomCBS (NASDAQ:VIAC) stock like a stone. However, the media conglomerate’s results show the business is anything but on the ropes. Still, investors continue to price VIAC stock like it is. Why? The perception that its streaming efforts are “too little, too late.” Source: Jer123
Square (NYSE:SQ) still looks undervalued, although not as much as it was when I wrote about in July. One reason might be that the company’s all-stock acquisition deal for Afterpay Limited (OTCMKTS:AFTPY) could dilute earnings. As a result, my estimate is that SQ stock is still undervalued, but not as much as before. Source: IgorGolovniov
They call it FUD: fear, uncertainty and doubt. Based in China, ride-hailing giant Didi Global (NYSE:DIDI) has its fair share of problems, I’ll admit. But there’s also plenty of FUD surrounding DIDI stock. Source: Piotr Swat / Shutterstock.com For example, reports recently circulated claiming that China’s Beijing city government advised state-owned companies to invest in the
ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
Lucid Group (NASDAQ:LCID) should get a good boost in the fourth quarter, now that it has announced it’s producing and delivering electric vehicles (EVs). In other words, the factory is built, the line is ramped and Lucid Air EVs are coming out of Casa Grande, Arizona on schedule so far. This should act as a boon
DraftKings (NASDAQ:DKNG) stock has a boring scoreboard this year. Year-to-date it’s barely up 4%, which is only a quarter of the S&P 500’s performance. However, this boring score does not reflect the excitement in DKNG stock. Source: Tada Images / Shutterstock.com It has had six rallies, each more than 30%. Two of them were compound
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
Dutch Bros (NYSE:BROS) went public on Sept. 14 at $23.00 per share and immediately spiked to $43.32 as of Sept. 30. That is a gain of more than 88.3% and has led some to argue that BROS stock is overvalued. Source: Alexander Oganezov / Shutterstock.com I looked at some of the numbers in the initial public
On Sept. 24, Carnival (NYSE:CCL) reported that voyages for its fiscal third quarter turned free cash flow (FCF) positive. Of course, this does not mean that the company is profitable yet. But Carnival is now clearly on track. As a result, things look very bright for CCL stock moving forward. Source: Ruth Peterkin / Shutterstock.com
The market has experienced increased volatility over the last few weeks. Investors are still nervous about COVID and inflation, plus new issues including the debt ceiling debate and a possibility of an Evergrande default in China. At times like these, investors may look to lower their risk profile. One way to do that is to
In reviewing the opportunity in Roku (NASDAQ:ROKU) stock, I need to start with an apology. A few years ago, I harshly judged it for its delay in reaching profitability. I had good reason at the time, since after 16 years they were still losing money. Management has most definitely shut me up, though, and that’s
The coronavirus pandemic disrupted many businesses and was a boon to others. One sector that’s been riding high is the pharmaceutical industry. That’s especially true for companies that have brought a Covid-19 vaccine to market. Vaccine developer Novavax (NASDAQ:NVAX) is a perfect example. NVAX stock rose from relative obscurity with a share price of just
Cathie Wood just purchased a bunch of Peloton (NASDAQ:PTON) shares after PTON stock crumbled from $125 in late July to below $90 in late September. This stock is at the lowest level its been at since its recall issues earlier this year. And this is as low as it gets. Source: JHVEPhoto / Shutterstock.com As
Nvidia’s (NASDAQ:NVDA) core businesses have been firing on all cylinders, and its move into other profitable verticals has resulted in consistent top-line growth. The company’s market value has grown at an incredible pace over the past decade. Yet, NVDA stock still has a ton of upside left with new catalysts that will amplify growth in
Sofi Technologies (NASDAQ:SOFI) reported good Q2 results on Aug. 12, including record quarterly growth of 101% year-over-year (YoY) and adj. revenue up 74%. The problem is, as I wrote last month, SOFI stock looks to be fairly valued now. That seems to imply that the stock might not rise. Or could it? This article will
Biotech stocks are infamously one of the most volatile sectors in the stock market. Investors often venture into speculative companies with no proven pipelines. Emerging firms with a pipeline of drugs and products still in the clinical phase post little to no revenue. They raise cash by tapping capital markets to pay for research and
Opendoor (NASDAQ:OPEN), the digital platform for residential real estate, is still quite undervalued even though OPEN stock is up a good deal. As I predicted in my article back in July, the company’s massive buying spree — along with rising real estate market prices — has led to positive profits. Source: Shutterstock OPEN stock has actually
- « Previous Page
- 1
- …
- 80
- 81
- 82
- 83
- 84
- …
- 98
- Next Page »